Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer
Sponsor: Singlera Genomics Inc.
Summary
This study screened and identified effective methylation markers in breast cancer, established a detection system for early screening and early diagnosis, and provided a research basis for the embryonic form of non-invasive breast cancer early screening products in later incubation. Then, the plasma ctDNA polygene methylation test was performed for early and middle stage breast cancer patients who were to receive radical surgery for initial treatment, and the predictive effect of postoperative plasma ctDNA methylation status on postoperative prognosis of breast cancer was discussed. In addition, the application value of dynamic monitoring of ctDNA methylation in plasma for postoperative recurrence risk monitoring was explored through regular postoperative follow-up of stage I-III breast cancer patients undergoing radical surgery.
Official title: Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer Based on Plasma ctDNA Methylation Markers
Key Details
Gender
FEMALE
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-03-07
Completion Date
2026-03
Last Updated
2024-04-17
Healthy Volunteers
Yes
Conditions
Locations (1)
Beijing Friendship Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China